Stock data
AIM ImmunoTech Inc. (AIM)
AIM ImmunoTech Inc. (AIM) reported revenue of US$0.09M and net income of -US$13.96M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.09M | — | -US$11.66M | -US$13.96M | — |
| 2024 | US$0.17M | — | -US$19.77M | -US$17.32M | — |
| 2023 | US$0.20M | — | -US$31.92M | -US$28.96M | — |
| 2022 | US$0.14M | — | -US$19.92M | -US$19.45M | — |
| 2021 | US$0.14M | — | -US$18.84M | -US$19.13M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.03M | -US$3.79M | — |
| 2026-03-31 | US$0.02M | -US$3.02M | — |
| 2025-12-31 | US$0.02M | -US$4.17M | — |
| 2025-09-30 | US$0.03M | -US$3.28M | — |
| 2025-06-30 | US$0.03M | -US$2.79M | — |
| 2025-03-31 | US$0.02M | -US$3.71M | — |
| 2024-12-31 | US$0.04M | -US$5.97M | — |
| 2024-09-30 | US$0.04M | -US$3.70M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.